DOI QR코드

DOI QR Code

The immune enhancing effects and characteristics of Bifidobacterium longum and Bifidobacterium breve for the probiotic use in humans and animals

  • Park, Ho-Eun (Laboratory of Bacteriology College of Veterinary Medicine Chungbuk National University) ;
  • Um, Hyun-Bum (Laboratory of Bacteriology College of Veterinary Medicine Chungbuk National University) ;
  • Lee, Wan-Kyu (Laboratory of Bacteriology College of Veterinary Medicine Chungbuk National University)
  • Received : 2018.08.28
  • Accepted : 2018.09.20
  • Published : 2018.12.31

Abstract

The purpose of this study was to investigate probiotic characteristics and immune enhancing effects of Bifidobacterium (B.) longum KBB1-26 and BIF-4, B. breve KBB5-22 isolated from human intestine for probiotic use in humans and animals. We measured acid, bile and heat tolerance, antimicrobial activity against pathogenic bacteria, Escherichia (E.) coli, Salmonella (S.) Enteritidis, Staphylococcus (S.) aureus, and Listeria (L.) monocytogenes. Immune enhancing effects of B. longum and B. breve were investigated by measuring nitric oxide (NO), nuclear factor ($NF-{\kappa}b$), $interleukin-1{\beta}$ ($IL-1{\beta}$), interleukin-6 (IL-6), interleukin-12 (IL-12) and tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$) in RAW 264.7 cells or RAW BLUE cells. B. longum KBB1-26 was survived at pH 2.0. B. longum KBB1-26 and BIF-4, B. breve KBB5-22 also showed tolerance to 0.3% of oxgall bile salt. B. longum KBB1-26 was able to survive at $70^{\circ}C$ and $80^{\circ}C$ for 20 min. KBB1-26 showed the antimicrobial inhibition zone to pathogenic bacteria such as E. coli (12 mm), S. Enteritidis (14 mm), S. aureus (14 mm) and L. monocytogenes (41 mm). The production of NO ($4.5{\pm}0.00{\mu}M/mL$) and $IL-1{\beta}$ ($39.7{\pm}0.55pg/mL$) of KBB1-26 significantly higher than BIF-4 and KBB5-22, respectively. In addition, KBB1-26 and KBB5-22 induce the production of high level of $TNF-{\alpha}$ and IL-6 in macrophages. Collectively, B. longum KBB1-26 have acid, bile, heat tolerance, antimicrobial activity and immune enhancing effects. These results suggest that KBB1-26 can be used as probiotics for humans and animals.

Keywords

Acknowledgement

Supported by : 농촌진흥청

References

  1. Sarkar A, and Mandal S. Bifidobacteria-Insight into clinical outcomes and mechanisms of its probiotic action. Microbiological Research 2016;192:159-171. https://doi.org/10.1016/j.micres.2016.07.001
  2. Felis GE, and Dellaglio F. Taxonomy of Lactobacilli and Bifidobacteria. Current Issues in Intestinal Microbiology 2007;8:44-61.
  3. Mitsuoka T, and Kaneuchi C. Ecology of the bifidobacteria. The American Journal of Clinical Nutrition 1977;30:1799-1810. https://doi.org/10.1093/ajcn/30.11.1799
  4. Gibson GR, and Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiology Letters 1994;118:121-127. https://doi.org/10.1111/j.1574-6968.1994.tb06813.x
  5. Gibson GR, and Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. The Journal of Applied Bacteriology 1994;77:412-420. https://doi.org/10.1111/j.1365-2672.1994.tb03443.x
  6. Russell DA, Ross RP, Fitzgerald GF, and Stanton C. Metabolic activities and probiotic potential of bifidobacteria. International Journal of Food Microbiology 2011;149:88-105. https://doi.org/10.1016/j.ijfoodmicro.2011.06.003
  7. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, and Hosono A. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Journal of Dairy Science 2003;86:2452-2461. https://doi.org/10.3168/jds.S0022-0302(03)73839-9
  8. He T, Priebe MG, Zhong Y, Huang C, Harmsen HJ, Raangs GC, Antoine JM, Welling GW, and Vonk RJ. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. Journal of Applied Microbiology 2008;104:595-604.
  9. Le Leu RK, Hu Y, Brown IL, Woodman RJ, and Young GP. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 2010;31:246-251. https://doi.org/10.1093/carcin/bgp197
  10. Ranadheera RDCS, Baines SK, and Adams MC. Importance of food in probiotic efficacy. Food Research International 2010;43:1-7. https://doi.org/10.1016/j.foodres.2009.09.009
  11. Hyronimus B, Le Marrec C, Sassi AH, and Deschamps A. Acid and bile tolerance of spore-forming lactic acid bacteria. International Journal of Food Microbiology 2000;61:193-197. https://doi.org/10.1016/S0168-1605(00)00366-4
  12. George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, and Das G. Benefaction of probiotics for human health: a review. Journal of Food and Drug Analysis 2018;26:927-939. https://doi.org/10.1016/j.jfda.2018.01.002
  13. Oh S, Kim SH, and Worobo RW. Characterization and purification of a bacteriocin produced by a potential probiotic culture, Lactobacillus acidophilus 30SC. Journal of Dairy Science 2000;83:2747-2752. https://doi.org/10.3168/jds.S0022-0302(00)75169-1
  14. Choi HJ, Kim JY, Shin MS, Lee SM, and WK. L. Immuno-enhancing Effects of Lactobacillus salivarius JWS 58 and Lactobacillus plantarum JWS 1354 isolated from duck. Korean Journal of Veterinary Research 2011;51:281-288.
  15. Choi HJ, Shin MS, Lee SM, and Lee WK. Immunomodulatory properties of Enterococcus faecium JWS 833 isolated from duck intestinal tract and suppression of Listeria monocytogenes infection. Microbiology and Immunology 2012;56:613-620. https://doi.org/10.1111/j.1348-0421.2012.00486.x
  16. Akira S, Hirano T, Taga T, and Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 1990;4:2860-2867. https://doi.org/10.1096/fasebj.4.11.2199284
  17. Tejero-Sarinena S, Barlow J, Costabile A, Gibson GR, and Rowland I. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains? Anaerobe 2013;24:60-65. https://doi.org/10.1016/j.anaerobe.2013.09.011
  18. Yasui H, Kiyoshima J, and Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clinical and diagnostic laboratory immunology 2004;11:675-679.
  19. Park HE, and Lee WK. Immunomodulatory effects of mixed Weissella cibaria JW15 with water extract of black soybean and burdock on Listeria monocytogenes infection in mice. J Biomed Transl Res 2017;18:1-6.
  20. Ryu JS, Han SK, Shin MS, and WK. L. In vitro selection of lactic acid bacteria for probiotic use in pig. Korean Journal of Veterinary Service 2009;32:33-41.
  21. Fleming HP, Etchells JL, and Costilow RN. Microbial inhibition by an isolate of Pediococcus from cucumber brines. Applied Microbiology 1975;30:1040-1042.
  22. Ahn SB, Park HE, Lee SM, Kim SY, Shon MY, and Lee WK. Characteristics and immuno-modulatory effects of Weissella cibaria JW15 isolated from Kimchi, Korea traditional fermented food, for probiotic use. J Biomed Res 2013;14:206-212. https://doi.org/10.12729/jbr.2013.14.4.206
  23. Park SM, Park HE, and Lee WK. Selection and immunomodulatory evaluation of lactic acid bacteria suitable for use as canine probiotics. Korean J Vet Res 2015;55:81-88. https://doi.org/10.14405/kjvr.2015.55.2.81
  24. Matsumoto M, Ohishi H, and Benno Y. H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. International Journal of Food Microbiology 2004;93:109-113. https://doi.org/10.1016/j.ijfoodmicro.2003.10.009
  25. Lin WH, Hwang CF, Chen LW, and Tsen HY. Viable counts, characteristic evaluation for commercial lactic acid bacteria products. Food Microbiology 2006;23:74-81. https://doi.org/10.1016/j.fm.2005.01.013
  26. Ding WK, and Shah NP. Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria. Journal of Food Science 2007;72:M446-450. https://doi.org/10.1111/j.1750-3841.2007.00565.x
  27. El-Kholy, AM., El-Shinawy SH., El-Shinawy, AMS. Meshref, and Korny AM. Screening of antagonistic activity of probiotic bacteria against some food-borne Pathogens. Journal of Food Biosciences and Technology 2014;4:1-14.
  28. Tejero-Sarinena S, Barlow J, Costabile A, Gibson GR, and Rowland I. In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids. Anaerobe 2012;18:530-538. https://doi.org/10.1016/j.anaerobe.2012.08.004
  29. Forestier C, De Champs C, Vatoux C, and Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Research in Microbiology 2001;152:167-173. https://doi.org/10.1016/S0923-2508(01)01188-3
  30. Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, and Servin AL. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000;47:646-652. https://doi.org/10.1136/gut.47.5.646
  31. Erickson KL, and Hubbard NE. Probiotic immunomodulation in health and disease. The Journal of Nutrition 2000;130:403S-409S. https://doi.org/10.1093/jn/130.2.403S
  32. Taverniti V, and Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes & Nutrition 2011;6:261-274. https://doi.org/10.1007/s12263-011-0218-x
  33. Kim DW, Cho SB, Lee HJ, Chung WT, Kim KH, Hwangbo J, Nam IS, Cho YI, Yang MP, and Chung IB. Comparison of cytokine and nitric oxide induction in murine macrophages between whole cell and enzymatically digested Bifidobacterium sp. obtained from monogastric animals. Journal of Microbiology 2007;45:305-310.
  34. Marcinkiewicz J, Ciszek M, Bobek M, Strus M, Heczko PB, Kurnyta M, Biedron R, and Chmielarczyk A. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. International Journal of Experimental Pathology 2007;88:155-164. https://doi.org/10.1111/j.1365-2613.2007.00530.x
  35. Kim DW, Cho SB, Yun CH, Jeong HY, Chung WT, Choi CW, Lee HJ, Nam IS, Suh GH, Lee SS, and Lee BS. Induction of cytokines and nitric oxide in murine macrophages stimulated with enzymatically digested lactobacillus strains. Journal of Microbiology 2007;45:373-378.
  36. Park SY, Ji GE, Ko YT, Jung HK, Ustunol Z, and Pestka JJ. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. International Journal of Food Microbiology 1999;46:231-241. https://doi.org/10.1016/S0168-1605(98)00197-4
  37. He F, Morita H, Hashimoto H, Hosoda M, Kurisaki J, Ouwehand AC, Isolauri E, Benno Y, and Salminen S. Intestinal Bifidobacterium species induce varying cytokine production. The Journal of Allergy and Clinical Immunology 2002;109:1035-1036. https://doi.org/10.1067/mai.2002.124894

Cited by

  1. Suitability of Lactobacillus plantarum SPC-SNU 72-2 as a Probiotic Starter for Sourdough Fermentation vol.29, pp.11, 2018, https://doi.org/10.4014/jmb.1907.07039